Search Results
Mar 31, 2026, 08:15 ET Ramaco Resources, Inc. Announces Internal Corporate Reorganization
metallurgical coal production and sales business,A rare earth and critical mineral resource and sales development,Various mineral rights and related infrastructure ownership encompassing both coal and various future potential rare earth elements and critical minerals, as well asFuture
More news about: Ramaco Resources, Inc.
Mar 31, 2026, 08:15 ET Maryland Businesses Announce Breakthrough Technologies, Portfolio Expansions and Customer Relief
milestones early in 2026 that advance its commitment to making a brighter future for patients living with progressive, chronic, and possibly terminal rare diseases. These include a
More news about: Maryland Marketing Partnership
Mar 31, 2026, 08:00 ET Holiday Inn Express & Suites Johnstown Wins Prestigious IHG Torchbearer Award
significant as it marks a continued standard of excellence under Plamondon Hospitality Partners' management. Achieving this honor over several years is a rare accomplishment in the industry and underscores the hotel's sustained performance.The Holiday Inn Express & Suites Johnstown, located at 1440
More news about: Plamondon Hospitality Partners
Mar 31, 2026, 08:00 ET American Lithium Minerals, Inc. (OTC: AMLM) Announces the Acquisition of the Higginsville Gold Project in Western Australia
American Lithium Minerals Inc. (OTC: AMLM) ("AMLM" or the "Company"), a dynamic exploration-stage company focused on critical metals, precious metals, and rare earth elements is pleased to announce that it has completed the acquisition of the Higginsville Project, a package of four granted prospecting
More news about: American Lithium Minerals, Inc
Mar 31, 2026, 08:00 ET Safi Biotherapeutics Inc. and DesiCorp Inc. Initiate Collaboration to Support Freeze-Drying of mRBCs
launched the company in 2020 as part of the U.S. Department of Defense On-Demand Blood program. Safi's mRBC product has been granted U.S. FDA Rare Pediatric Disease Designation and Orphan Drug Designation for use in chronic transfusion of patients with SCD.For more information on Safi, visit:
More news about: Safi Biotherapeutics
Mar 31, 2026, 07:46 ET Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year
heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do
More news about: Novo Nordisk
Mar 31, 2026, 07:30 ET Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the year ended December 31, 2025.
More news about: SOLIGENIX, INC.
Mar 31, 2026, 07:03 ET Sobi publishes Annual and Sustainability Report for 2025
delivering on Sobi's mission to deliver therapies for people living with rare diseases. Revenue in 2025 grew by 15 per cent at CER to SEK 28 B, and Sobi advanced its pipeline with the potential to change the standard of care in several rare and severe diseases.The report includes the audited Annual Report
More news about: Swedish Orphan Biovitrum AB
Mar 31, 2026, 07:00 ET Sobi publishes Annual and Sustainability Report for 2025
delivering on Sobi's mission to deliver therapies for people living with rare diseases. Revenue in 2025 grew by 15 per cent at CER to SEK 28 B, and Sobi advanced its pipeline with the potential to change the standard of care in several rare and severe diseases.The report includes the audited Annual Report
More news about: Swedish Orphan Biovitrum AB
Mar 31, 2026, 06:30 ET Keenova Announces Unaudited Fourth Quarter 2025 Financial Results
KeenovaKeenova Therapeutics is a leading U.S.-focused branded therapeutics company that strives to help patients with rare or unaddressed conditions live happier and healthier lives.Keenova's rare disease capabilities underpin our diversified brands portfolio, which is focused across a wide range of specialty
More news about: Keenova Therapeutics
Mar 31, 2026, 06:25 ET Solar Industry Veteran Mr. Rhone Resch Joins TOYO as Chief Strategy Officer
manufacturing footprint, accelerating its U.S. market expansion, and strengthening partnerships across the solar value chain."Rhone brings a rare combination of industry leadership, commercial insight, and policy expertise," said Mr. Takahiko Onozuka, the CEO of TOYO. "He has been closely involved
More news about: TOYO Co., Ltd
Mar 31, 2026, 03:16 ET Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program
-- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced initial learnings from the 12-month Expanded Access Program (EAP) with its lead drug candidate
More news about: Cereno Scientific
Mar 31, 2026, 03:12 ET Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program
-- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced initial learnings from the 12-month Expanded Access Program (EAP) with its lead drug candidate
More news about: Cereno Scientific
Mar 31, 2026, 02:10 ET Abbisko Therapeutics' FGFR2/3 Inhibitor ABSK061 Receives FDA IND Clearance for Achondroplasia in Children
for ABSK061, a highly selective small-molecule FGFR2/3 inhibitor, for the treatment of children with achondroplasia (ACH). Coupled with the recent Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) granted by the FDA, this will help Abbisko accelerate the overseas clinical development
More news about: Abbisko Therapeutics Co., Ltd.
Mar 31, 2026, 02:00 ET OpenBox AI Launches First Enterprise AI Trust Platform Built for Everyone, Backed by $5M Seed Round
technical depth to build this right with the regulatory experience to understand precisely what enterprises and regulators require. That combination is rare, and the window to define this category is now."— Prashant Malik, Co-creator of Apache Cassandra & General Partner, Tykhe VenturesTHE
More news about: OpenBox AI
Mar 31, 2026, 02:00 ET OpenBox AI Launches First Enterprise AI Trust Platform Built for Everyone, Backed by $5M Seed Round
technical depth to build this right with the regulatory experience to understand precisely what enterprises and regulators require. That combination is rare, and the window to define this category is now."— Prashant Malik, Co-creator of Apache Cassandra & General Partner, Tykhe VenturesTHE
More news about: OpenBox AI
Mar 30, 2026, 19:02 ET DAWSON GEOPHYSICAL REPORTS FOURTH QUARTER and YEAR END 2025 RESULTS
equipment from our customers. We have expanded our customer base to include more unconventional exploration such as carbon capture, geothermal, and critical rare-earth minerals as well as other usages of seismic acquisition capabilities.We believe that the Dawson team has shown continuous improvement over
More news about: Dawson Geophysical Company
Mar 30, 2026, 17:28 ET RARE Deadline: RARE Investors with Losses in Excess of $100K Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Mar 30, 2026, 16:57 ET Ex-Shark Tank Founder and Thiel Fellow Raises $7M led by True Ventures for Tenkara to Build Ops Agents for US Manufacturers
vertically integrated manufacturing plants, developing deep empathy for the customers he now serves with Tenkara. This kind of customer understanding is rare, and as domestic manufacturing becomes increasingly important, it's exactly what this market needs. We believe Tenkara is foundational to how the next
More news about: Tenkara
Mar 30, 2026, 16:20 ET Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
oral tablet intended to treat hyperphagia. Soleno has described this condition as "the most life-limiting aspect" of Prader-Willi Syndrome ("PWS"), a rare genetic disorder that causes physical, mental, and behavioral problems.The report triggered a massive 26% selloff in the price of the company
More news about: Hagens Berman Sobol Shapiro LLP
Mar 30, 2026, 16:13 ET Madison Avenue Couture Palm Beach Celebrates One Year Anniversary with a Celebration at The Colony Hotel
service, and a carefully curated inventory, Madison Avenue Couture is the trusted resource for collectors and fashion insiders seeking store-fresh, rare, and iconic pieces. The company opened its second showroom in Palm Beach, Florida, in 2025, located in Via Mizner on Worth Avenue. Clients can visit
More news about: Madison Avenue Couture, Inc.
Mar 30, 2026, 15:52 ET QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data
history as a comparator.Ineligibility for "Plausible Mechanism" Pathway: The official disputed AMT-130's eligibility for streamlined rare-disease pathways, noting it is not an individualized treatment.The recent reports follow the filing of a securities class action suit.Investors
More news about: Hagens Berman Sobol Shapiro LLP
Mar 30, 2026, 15:14 ET nugs Offers Free Livestream of Opening Songs from Bruce Springsteen and The E Street Band's Opening Night Show
the leading platform for live concert streaming and official artist recordings, will partner with Bruce Springsteen and The E Street Band to deliver a rare livestream moment as the band kicks off their Land of Hope and Dreams American Tour on March 31 from Minneapolis, MN. For tour dates and ticket
More news about: nugs
Mar 30, 2026, 13:00 ET uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline
N.V. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:uniQure is a biotechnology company developing gene therapies for rare diseases, including Huntington's disease (HD). uniQure's leading drug candidate is AMT-130, a novel gene therapy being developed to slow the progression
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 30, 2026, 11:01 ET Malala Fund appoints Nabila Aguele as new CEO
at an important moment in our journey. We are deeply thankful for all she has contributed. I have seen Nabila's leadership up close, and she brings a rare combination of wisdom, integrity and deep understanding of the realities girls face. She is the right leader to carry this work forward."Lena
More news about: Malala Fund